LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study

Clinical trial NCT05282017 · COMPLETED

Trial details

NCT number: NCT05282017
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19, SARS-CoV-2

Start date: 2022-02-01
Primary completion: 2023-04-19
Enrollment: 792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.